Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Stephanie Gardner

Concepts (216)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
3
2012
146
0.850
Why?
Rural Health Services
2
2024
169
0.810
Why?
Curriculum
5
2012
400
0.740
Why?
Students, Pharmacy
4
2010
124
0.640
Why?
Schools, Pharmacy
2
2010
53
0.640
Why?
Blood Pressure
8
2008
531
0.590
Why?
Telemedicine
1
2024
469
0.570
Why?
Dental Caries
1
2016
8
0.510
Why?
Schools, Dental
1
2016
7
0.510
Why?
Tetrazoles
2
2008
41
0.500
Why?
Hypertension
5
2008
544
0.450
Why?
Dietary Supplements
7
2005
449
0.390
Why?
Faculty
2
2010
72
0.380
Why?
Pharmacy
1
2012
54
0.370
Why?
Plant Preparations
5
2005
39
0.370
Why?
Career Choice
1
2012
112
0.360
Why?
Patient Care Team
2
2003
258
0.360
Why?
Antihypertensive Agents
3
2003
125
0.350
Why?
Arkansas
5
2024
1985
0.320
Why?
Biphenyl Compounds
1
2008
31
0.310
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
43
0.300
Why?
Diabetes Mellitus, Type 1
2
2003
199
0.300
Why?
School Admission Criteria
1
2008
35
0.300
Why?
Benzimidazoles
1
2008
48
0.300
Why?
Blood Pressure Monitoring, Ambulatory
6
2008
36
0.300
Why?
Ephedrine
5
2003
21
0.300
Why?
Clinical Competence
2
2010
398
0.290
Why?
Delivery of Health Care
2
2024
303
0.290
Why?
Niacin
2
1997
5
0.270
Why?
Intergenerational Relations
1
2006
4
0.270
Why?
Humans
37
2024
50503
0.270
Why?
Diabetes Mellitus, Type 2
3
2004
519
0.270
Why?
Angiotensin Receptor Antagonists
2
2004
18
0.270
Why?
Students
2
2023
223
0.260
Why?
Probucol
1
2005
3
0.260
Why?
Coronary Restenosis
1
2005
31
0.250
Why?
Interprofessional Relations
1
2006
83
0.250
Why?
Angiotensin II
2
2004
160
0.240
Why?
Alkaloids
3
2000
28
0.230
Why?
Phytotherapy
2
2003
45
0.220
Why?
Hospitals, Rural
1
2024
21
0.220
Why?
Ephedra
1
2003
8
0.220
Why?
Electrocardiography, Ambulatory
1
2003
23
0.220
Why?
Rural Health
1
2024
89
0.220
Why?
Hemostasis
1
2003
59
0.210
Why?
Self Care
1
2003
135
0.200
Why?
Community Pharmacy Services
1
2003
66
0.200
Why?
Administrative Personnel
1
2002
13
0.190
Why?
Imidazoles
1
2003
127
0.190
Why?
Ephedra sinica
2
1998
2
0.190
Why?
Education, Medical, Undergraduate
1
2002
86
0.180
Why?
Academic Medical Centers
1
2002
149
0.180
Why?
Patient Education as Topic
1
2003
320
0.170
Why?
Male
21
2023
25907
0.170
Why?
Rural Population
1
2024
554
0.160
Why?
Chromatography, High Pressure Liquid
2
2004
326
0.160
Why?
Cytochrome P-450 Enzyme System
3
2005
194
0.160
Why?
Hypercholesterolemia
2
1997
38
0.150
Why?
Attitude of Health Personnel
1
2002
352
0.150
Why?
Female
20
2023
27081
0.150
Why?
Erectile Dysfunction
1
1999
90
0.150
Why?
Pravastatin
1
1997
18
0.140
Why?
Primary Health Care
1
2001
366
0.140
Why?
Anticholesteremic Agents
1
1997
27
0.140
Why?
Heart Rate
5
2003
307
0.140
Why?
Adult
14
2023
13577
0.140
Why?
Sodium
2
1996
92
0.130
Why?
Lovastatin
1
1996
9
0.130
Why?
Hypolipidemic Agents
1
1996
28
0.130
Why?
Erythromycin
1
1996
10
0.130
Why?
Torsades de Pointes
1
1996
15
0.130
Why?
Hyperlipidemias
1
1996
52
0.130
Why?
Polyethylene Glycols
1
1995
86
0.120
Why?
Enzyme Inhibitors
1
1997
377
0.120
Why?
Pharmacies
1
1995
60
0.110
Why?
Pilot Projects
2
2008
698
0.110
Why?
Dose-Response Relationship, Drug
3
2008
1372
0.110
Why?
Clinical Trials as Topic
3
2005
486
0.110
Why?
Aged
10
2008
9741
0.110
Why?
Seroepidemiologic Studies
2
2023
50
0.100
Why?
Middle Aged
10
2008
12611
0.100
Why?
Tomography, Emission-Computed
1
1992
53
0.100
Why?
Education, Pharmacy, Continuing
1
1991
4
0.100
Why?
Accreditation
1
1991
61
0.090
Why?
Education, Medical, Continuing
1
1991
71
0.090
Why?
Organizational Policy
1
2010
39
0.090
Why?
Pharmacists
1
1991
145
0.090
Why?
Anti-Bacterial Agents
1
1996
745
0.090
Why?
Social Environment
1
2010
79
0.080
Why?
Heart Failure
1
1995
528
0.080
Why?
Drug Interactions
4
2004
206
0.080
Why?
Plant Extracts
2
2004
174
0.080
Why?
Phenotype
4
2005
739
0.080
Why?
Misoprostol
1
2008
5
0.080
Why?
Diclofenac
1
2008
9
0.080
Why?
Drug Therapy, Combination
3
2004
384
0.080
Why?
Sodium Chloride
1
2008
55
0.070
Why?
Blood Glucose
2
2003
446
0.070
Why?
Guidelines as Topic
1
2008
109
0.070
Why?
Adolescent
3
2023
6443
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2008
121
0.070
Why?
Guideline Adherence
1
2008
136
0.070
Why?
Drugs, Investigational
1
2005
14
0.060
Why?
Valerian
1
2005
2
0.060
Why?
Cimicifuga
1
2005
8
0.060
Why?
Kava
1
2005
11
0.060
Why?
Hydrastis
1
2005
10
0.060
Why?
Educational Measurement
1
2007
206
0.060
Why?
Citrus
1
2004
5
0.060
Why?
Echinacea
1
2004
5
0.060
Why?
Aryl Hydrocarbon Hydroxylases
1
2005
74
0.060
Why?
Molecular Structure
1
2005
296
0.060
Why?
Prospective Studies
3
2008
2378
0.060
Why?
Cognition
1
2007
346
0.060
Why?
Antioxidants
1
2005
239
0.050
Why?
Cost Savings
1
2003
57
0.050
Why?
Central Nervous System Stimulants
2
2004
209
0.050
Why?
Kidney
1
2008
696
0.050
Why?
Diastole
1
2003
70
0.050
Why?
Bradycardia
1
2003
37
0.050
Why?
Systole
1
2003
72
0.050
Why?
Receptors, Angiotensin
1
2003
12
0.050
Why?
Prescription Fees
1
2003
14
0.050
Why?
Antibodies, Viral
1
2023
94
0.050
Why?
Tachycardia, Ventricular
1
2003
44
0.050
Why?
Plants, Medicinal
2
2000
35
0.050
Why?
Health Services Research
1
2003
152
0.050
Why?
Reference Values
1
2003
307
0.050
Why?
Mixed Function Oxygenases
1
2002
25
0.050
Why?
Amphetamines
1
2002
29
0.050
Why?
Kidney Diseases
1
2004
213
0.050
Why?
Universities
1
2023
171
0.050
Why?
Time Factors
3
2005
2935
0.050
Why?
Program Evaluation
1
2003
349
0.050
Why?
Cytochrome P-450 CYP2E1
1
2002
111
0.050
Why?
Patient Compliance
1
2003
233
0.050
Why?
Models, Educational
1
2002
32
0.050
Why?
Sympathomimetics
2
1998
21
0.050
Why?
Methylphenidate
1
2002
76
0.050
Why?
Body Weight
1
2003
517
0.050
Why?
Midazolam
3
2005
37
0.040
Why?
Longitudinal Studies
1
2023
735
0.040
Why?
Attention Deficit Disorder with Hyperactivity
1
2002
172
0.040
Why?
Caffeine
3
2005
64
0.040
Why?
Herb-Drug Interactions
3
2005
31
0.040
Why?
Body Mass Index
1
2003
677
0.040
Why?
Plants, Toxic
1
1999
10
0.040
Why?
Feasibility Studies
1
2001
390
0.040
Why?
Evaluation Studies as Topic
1
1998
107
0.040
Why?
Child
2
2008
6906
0.040
Why?
Fructosamine
1
1997
1
0.040
Why?
Lipoprotein(a)
1
1997
6
0.040
Why?
Cholesterol, LDL
1
1997
41
0.040
Why?
Drugs, Chinese Herbal
1
1997
5
0.030
Why?
Cross-Over Studies
3
2008
228
0.030
Why?
Comorbidity
1
1999
623
0.030
Why?
United States
2
2002
4955
0.030
Why?
Cross-Sectional Studies
1
2022
1610
0.030
Why?
Nifedipine
1
1996
24
0.030
Why?
Ethanol
1
1999
336
0.030
Why?
Pancreas Transplantation
1
1996
21
0.030
Why?
Calcium Channel Blockers
1
1996
62
0.030
Why?
Circadian Rhythm
1
1996
89
0.030
Why?
Pharmaceutical Vehicles
1
1995
3
0.030
Why?
Models, Biological
1
1999
716
0.030
Why?
Electrolytes
1
1995
27
0.030
Why?
Reproducibility of Results
1
1998
1197
0.030
Why?
Isoenzymes
2
2005
168
0.030
Why?
Drug Administration Schedule
2
2005
370
0.030
Why?
Kidney Transplantation
1
1996
189
0.030
Why?
Ginkgo biloba
2
2005
7
0.030
Why?
Panax
2
2005
6
0.030
Why?
Allyl Compounds
2
2005
11
0.030
Why?
Hypericum
2
2005
13
0.030
Why?
Electrocardiography
1
1996
266
0.030
Why?
Sulfides
2
2005
28
0.030
Why?
Critical Care
1
1996
214
0.030
Why?
Young Adult
1
2023
4102
0.030
Why?
Treatment Outcome
1
2003
5283
0.030
Why?
Mass Screening
1
1995
344
0.020
Why?
Databases, Factual
1
1995
673
0.020
Why?
Specialty Boards
1
1991
24
0.020
Why?
Capsules
2
2005
28
0.020
Why?
Public Policy
1
1991
35
0.020
Why?
Retrospective Studies
1
2003
6263
0.020
Why?
Animals
1
2005
13124
0.020
Why?
Data Collection
1
1991
280
0.020
Why?
Aged, 80 and over
1
1996
3226
0.020
Why?
Sex Factors
2
2002
712
0.020
Why?
Risk Factors
1
1995
3724
0.020
Why?
Double-Blind Method
1
2008
708
0.020
Why?
Chlorzoxazone
1
2005
5
0.020
Why?
Debrisoquin
1
2004
1
0.010
Why?
Serenoa
1
2004
7
0.010
Why?
GABA Modulators
1
2004
9
0.010
Why?
Adrenergic Agents
1
2004
14
0.010
Why?
Solubility
1
2004
71
0.010
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2004
74
0.010
Why?
Patient Selection
1
2005
259
0.010
Why?
Administration, Oral
1
2005
434
0.010
Why?
Kinetics
1
2004
623
0.010
Why?
Cytochrome P-450 CYP3A
1
2002
77
0.010
Why?
Analysis of Variance
1
2002
552
0.010
Why?
Sleep
1
2002
181
0.010
Why?
Drug Labeling
1
2000
11
0.010
Why?
Drug and Narcotic Control
1
2000
10
0.010
Why?
Predictive Value of Tests
1
2002
930
0.010
Why?
Metabolic Clearance Rate
1
1997
69
0.010
Why?
Half-Life
1
1997
86
0.010
Why?
Compartment Syndromes
1
1996
16
0.010
Why?
Area Under Curve
1
1997
179
0.010
Why?
Delayed-Action Preparations
1
1996
56
0.010
Why?
Pharmaceutical Preparations
1
1996
76
0.010
Why?
Dopamine
1
1996
175
0.010
Why?
Regression Analysis
1
1996
382
0.010
Why?
Immunosuppressive Agents
1
1996
225
0.010
Why?
Gardner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description